A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers
Clinical trial NCT03022175 · COMPLETED
Trial details
- NCT number
- NCT03022175
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-07-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.